Remdesivir, Favipiravir antiviral drugs ‘no game changers’ i
Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...
Get authentic, real-time news that helps you fight COVID-19 better.
Install PlexusMD App for doctors. It's free.
With pharmaceutical companies launching generic versions of Remdesivir and Favipiravir for COVID-19 treatment, medical experts on 22nd June said it was a “positive development” in the fight against the pandemic, but cautioned against regarding the antiviral drugs as “game-changers”.

Glenmark Pharmaceuticals has launched the antiviral drug Favipiravir, under the brand name FabiFlu, for the treatment of mild to moderate COVID-19 cases, while Cipla and Hetero have received approvals from the Drug Controller General of India (DCGI) to launch Remdesivir under the brand names Cipremi and Covifor respectively.

Dr. Vikas Maurya, Director, Department of Pulmonology and Sleep Disorders, Fortis Hospital, said drugs like Remdesivir and Favipiravir were “no game-changers” as they were used for other diseases and have now been found useful in some way in treating COVID-19 patients.

“It is not as if all those taking these drugs will recover. It has been found that they help reduce viral load but are not game-changers", Maurya said.

Whatever studies that have been done on these drugs are very limited so they cannot be called “game changers”, but their launch is a positive development as it is better to have something than nothing, said Dr. Rommel Tickoo, Associate Director, Internal Medicine, Max Healthcare, also echoed Maurya’s views.

Disclaimer: The article here is solely of the Hindustan Times & PlexusMD does not necessarily subscribe to it.

Source: https://www.hindustantimes.com/more-lifestyle/remdesivir-favipiravir-antiviral-drugs-no-game-changers-in-covid-19-fight/story-rzhrrbKGHPpWhZA4Zgml8M.html
k●●●l p●●●t and 7 others like this7 shares
Like
Comment
Share
Dr. S●●●●●m S●●●●y P●●●●●l
Dr. S●●●●●m S●●●●y P●●●●●l General Medicine
Interesting read ! It is good to see emergence of more options in the market against Covid19. I am confident more research will lead to finding of more options in future,and a concrete protocol can be created for covid treatment.
Jun 24, 2020Like1
Dr. D●●●●●●s T●●●●s
Dr. D●●●●●●s T●●●●s Pathology
The only game changer is convalescent plasma hyperimmune globulin for covid 19.
Jun 27, 2020Like